Synco Bio Partners Enters The Japanese Market As It Signs Its First Agreement With A Japanese Pharma
1st September 2009 -
Views: 732
SynCo Bio Partners B.V., the expert in long term GMP contract manufacturing of biopharmaceuticals announced today that it has expanded its business into a new geographical market, with the signing of a contract to manufacture a live biotherapeutic for an emerging Japanese pharmaceutical company.
Dementia Report An Urgent Reminder To Act - Acsa
1st September 2009 -
Views: 777
Aged and Community Services Australia (ACSA) has applauded the release of the Access Economics report – Keeping Dementia Front of Mind: Incidence and Preval ence 2009 – 2050 – commissioned by Alzheimer’s Australia.
New Results In Angina Patients: Fewer Heart Attacks With Procoralan(r) (ivabradine)*
1st September 2009 -
Views: 766
Important new findings in patients with angina participating in the BEAUTIFUL study show that there is a 42% reduction in heart attack with Procoralan(R) (ivabradine)*, as presented today at the European Society of Cardiology (ESC) Congress.
Crestor(r) Reduced The Risk Of Cardiovascular Events In Elderly Patients In New Analysis Of Jupiter
1st September 2009 -
Views: 785
These results are consistent with the CV risk reduction seen across all patients taking rosuvastatin in the primary JUPITER
analysis. This new analysis was presented today at the European Society of Cardiology (ESC) meeting in Barcelona, Spain.
The Confederation Of Meningitis Organisations (como) Applauds The Actions Of The Government Of Hong
31st August 2009 -
Views: 743
"The inclusion of the vaccine to the childhood immunisation program is a significant milestone for Hong Kong and its children," said Mr Langoulant.